These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches. Thompson CM; Petiot E; Lennaertz A; Henry O; Kamen AA Virol J; 2013 May; 10():141. PubMed ID: 23642219 [TBL] [Abstract][Full Text] [Related]
5. A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses. Yang JR; Chen CY; Kuo CY; Cheng CY; Lee MS; Cheng MC; Yang YC; Wu CY; Wu HS; Liu MT; Hsiao PW Antiviral Res; 2016 Feb; 126():8-17. PubMed ID: 26593980 [TBL] [Abstract][Full Text] [Related]
6. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity. Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice. Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076 [TBL] [Abstract][Full Text] [Related]
8. Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model. Pushko P; Sun X; Tretyakova I; Hidajat R; Pulit-Penaloza JA; Belser JA; Maines TR; Tumpey TM Vaccine; 2016 Oct; 34(44):5235-5242. PubMed ID: 27663671 [TBL] [Abstract][Full Text] [Related]
9. Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line. Venereo-Sanchez A; Simoneau M; Lanthier S; Chahal P; Bourget L; Ansorge S; Gilbert R; Henry O; Kamen A Vaccine; 2017 Jul; 35(33):4220-4228. PubMed ID: 28648546 [TBL] [Abstract][Full Text] [Related]
10. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets. Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674 [TBL] [Abstract][Full Text] [Related]
11. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase. Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana. Shoji Y; Prokhnevsky A; Leffet B; Vetter N; Tottey S; Satinover S; Musiychuk K; Shamloul M; Norikane J; Jones RM; Chichester JA; Green BJ; Streatfield SJ; Yusibov V Hum Vaccin Immunother; 2015; 11(1):118-23. PubMed ID: 25483524 [TBL] [Abstract][Full Text] [Related]
13. H5N1 influenza virus-like particle vaccine protects mice from heterologous virus challenge better than whole inactivated virus. Ren Z; Ji X; Meng L; Wei Y; Wang T; Feng N; Zheng X; Wang H; Li N; Gao X; Jin H; Zhao Y; Yang S; Qin C; Gao Y; Xia X Virus Res; 2015 Mar; 200():9-18. PubMed ID: 25599603 [TBL] [Abstract][Full Text] [Related]
14. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs. Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090 [TBL] [Abstract][Full Text] [Related]
15. Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses. Kapczynski DR; Tumpey TM; Hidajat R; Zsak A; Chrzastek K; Tretyakova I; Pushko P Vaccine; 2016 Mar; 34(13):1575-1581. PubMed ID: 26868083 [TBL] [Abstract][Full Text] [Related]
16. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus. Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810 [TBL] [Abstract][Full Text] [Related]
17. Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants. Le Mauff F; Mercier G; Chan P; Burel C; Vaudry D; Bardor M; Vézina LP; Couture M; Lerouge P; Landry N Plant Biotechnol J; 2015 Jun; 13(5):717-25. PubMed ID: 25523794 [TBL] [Abstract][Full Text] [Related]
18. Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro. Hendin HE; Pillet S; Lara AN; Wu CY; Charland N; Landry N; Ward BJ Vaccine; 2017 May; 35(19):2592-2599. PubMed ID: 28389100 [TBL] [Abstract][Full Text] [Related]
19. Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens. Song BM; Kang HM; Lee EK; Jung SC; Kim MC; Lee YN; Kang SM; Lee YJ Vaccine; 2016 Jan; 34(5):678-686. PubMed ID: 26691568 [TBL] [Abstract][Full Text] [Related]
20. The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae. Nerome K; Sugita S; Kuroda K; Hirose T; Matsuda S; Majima K; Kawasaki K; Shibata T; Poetri ON; Soejoedono RD; Mayasari NL; Agungpriyono S; Nerome R Vaccine; 2015 Jan; 33(1):117-25. PubMed ID: 25448101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]